Escalier Biosciences Competitors and Similar CompaniesClear all
MABION's competitors and similar companies include Rallybio.
 MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Rallybio Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins. | |
Founding Date | Founding Date 2007 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Konstantynów Łódzki, PL HQ | Locations New Haven, US HQ Farmington, US |
Employees | Employees 95 | Employees 28 |
Valuation ($) | Valuation ($) 21.7 m | Valuation ($) 43.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $858k (FY, 2025) |
Net income | Net income (zł62.6m) (FY, 2025) | Net income ($9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Rallybio
HQ
New Haven, US
Employees
28
Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins.
View company